Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

5-Iodo-2'-deoxyuridine (IUDR; NSC-39661) given intraventricularly in the treatment of progressive multifocal leukoencephalopathy.

Tarsy D, Holden EM, Segarra JM, Calabresi P, Feldman RG. 5-Iodo-2'-deoxyuridine (IUDR; NSC-39661) given intraventricularly in the treatment of progressive multifocal leukoencephalopathy. Cancer Chemother Rep. 1973 Feb; 57(1):73-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.